Human copper transporters: Mechanism, role in human diseases and therapeutic potential

Future Medicinal Chemistry

Volumn 1, Issue 6, 2009, Pages 1125-1142

  Gupta, Arnab ^a   Lutsenko, Svetlana ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; ADENOSINE TRIPHOSPHATASE; ADENOSINE TRIPHOSPHATE; CARBOPLATIN; CARRIER PROTEIN; CARRIER PROTEIN CTR1; CARRIER PROTEIN CTR2; CISPLATIN; COPPER; COPPER ADENOSINE TRIPHOSPHATASE; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE; DOXORUBICIN; MENKES PROTEIN; OXALIPLATIN; PACLITAXEL; PLATINUM; UNCLASSIFIED DRUG; VINCRISTINE; WILSON DISEASE PROTEIN;

BIOAVAILABILITY; CANCER INHIBITION; CELL MEMBRANE; COPPER DEFICIENCY; COPPER METABOLISM; DRUG SENSITIVITY; DRUG TRANSPORT; DRUG UPTAKE; ENZYME STRUCTURE; HUMAN; INTESTINE; LYMPHOMA; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SARCOMA;

ADENOSINE TRIPHOSPHATASES; ANTINEOPLASTIC AGENTS; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; DRUG RESISTANCE, NEOPLASM; ENTEROCYTES; HOMEOSTASIS; HUMANS; NEOPLASMS; PROTEIN CONFORMATION;

EID: 77953471147     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.09.84     Document Type: Review

References (104)

1. Nelson KT, Prohaska JR. Copper deficiency in rodents alters dopamine β-mono-oxygenase activity, mRNA and protein level. Br. J. Nutr. 102(1), 18-28 (2008).
2. Johnson WT, Anderson CM. Cardiac cytochrome C oxidase activity and contents of subunits 1 and 4 are altered in offspring by low prenatal copper intake by rat dams. J. Nutr. 138(7), 1269-1273 (2008).
3. Zhou Z, Johnson WT, Kang YJ. Regression of copper-deficient heart hypertrophy: reduction in the size of hypertrophic cardiomyocytes. J. Nutr. Biochem. 20(8), 621-628 (2008).
4. Smith AD, Botero S, Levander OA. Copper deficiency increases the virulence of amyocarditic and myocarditic strains of coxsackievirus B3 in mice. J. Nutr. 138(5), 849-855 (2008).
5. Gambling L, Andersen HS, McArdle HJ. Iron and copper, and their interactions during development. Biochem. Soc. Trans. 36(6), 1258-1261 (2008).
6. Keen CL, Uriu-Hare JY, Hawk SN et al. Effect of copper deficiency on prenatal development and pregnancy outcome. Am. J. Clin. Nutr. 67(Suppl. 5), S1003-S1011 (1998).
7. Kaler SG, Holmes CS, Goldstein DS et al. Neonatal diagnosis and treatment of Menkes disease. N. Engl. J. Med. 358(6), 605-614 (2008).
8. de Luis DA, Pacheco D, Izaola O, Terroba MC, Cuellar L, Martin T. Clinical results and nutritional consequences of biliopancreatic diversion: three years of follow-up. Ann. Nutr. Metab. 53(3-4), 234-239 (2008).
9. Ernst B, Thurnheer M, Schmid SM, Schultes B. Evidence for the necessity to systematically assess micronutrient status prior to bariatric surgery. Obes. Surg. 19(1), 66-73 (2009).
10. Halfdanarson TR, Kumar N, Li CY, Phyliky RL, Hogan WJ. Hematological manifestations of copper deficiency: a retrospective review. Eur. J. Haematol. 80(6), 523-531 (2008).
11. Marinella MA. Anemia following Roux-en-Y surgery for morbid obesity: a review. South Med. J. 101(10), 1024-1031 (2008).
12. Halfdanarson TR, Kumar N, Hogan WJ, Murray JA. Copper deficiency in celiac disease. J. Clin. Gastroenterol. 43(2), 162-164 (2009).
13. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin. Proc. 81(10), 1371-1384 (2006).
14. Das SK, Ray K. Wilson's disease: an update. Nat. Clin. Pract. Neurol. 2(9), 482-493 (2006)
15. Komatsu M, Sumizawa T, Mutoh M et al. Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance. Cancer Res. 60(5), 1312-1316 (2000).
16. Safaei R, Howell SB. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. Crit. Rev. Oncol. Hematol. 53(1), 13-23 (2005).
17. Lim CM, Cater MA, Mercer JF, La Fontaine S. Copper-dependent interaction of dynactin subunit p62 with the N terminus of ATP7B but not ATP7A. J. Biol. Chem. 281(20), 14006-14014 (2006).
18. Holloway ZG, Grabski R, Szul T et al. Activation of ADP-ribosylation factor regulates biogenesis of the ATP7A-containing trans-Golgi network compartment and its Cu-induced trafficking. Am. J. Physiol. Cell Physiol. 293(6), C1753-C1767 (2007).
19. Burkhead JL, Morgan CT, Shinde U, Haddock G, Lutsenko S. COMMD1 forms oligomeric complexes targeted to the endocytic membranes via specific interactions with phosphatidylinositol 4,5-bisphosphate. J. Biol. Chem. 284(1), 696-707 (2009).
20. Kim BE, Nevitt T, Thiele DJ. Mechanisms for copper acquisition, distribution and regulation. Nat. Chem. Biol. 4(3), 176-185 (2008).
21. Maryon EB, Molloy SA, Zimnicka AM, Kaplan JH. Copper entry into human cells: progress and unanswered questions. Biometals 20(3-4), 355-364 (2007).
22. Dancis A, Yuan DS, Haile D et al. Molecular characterization of a copper transport protein in S. cerevisiae: an unexpected role for copper in iron transport. Cell 76(2), 393-402 (1994).
23. Zhou B, Gitschier J. hCTR1: a human gene for copper uptake identified by complementation in yeast. Proc. Natl Acad. Sci. USA 94(14), 7481-7486 (1997).
24. Moller LB, Petersen C, Lund C, Horn N. Characterization of the hCTR1 gene: genomic organization, functional expression, and identification of a highly homologous processed gene. Gene 257(1), 13-22 (2000).
25. Kuo YM, Zhou B, Cosco D, Gitschier J. The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc. Natl Acad. Sci. USA 98(12), 6836-6841 (2001).
26. Kuo YM, Gybina AA, Pyatskowit JW, Gitschier J, Prohaska JR. Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J. Nutr. 136(1), 21-26 (2006).
27. Lee J, Pena MM, Nose Y, Thiele DJ. Biochemical characterization of the human copper transporter Ctr1. J. Biol. Chem. 277(6), 4380-4387 (2002).
28. Lee J, Petris MJ, Thiele DJ. Characterization of mouse embryonic cells deficient in the ctr1 high affinity copper transporter. Identification of a Ctr1-independent copper transport system. J. Biol. Chem. 277(43), 40253-40259 (2002).
29. Kim H, Son HY, Bailey SM, Lee J. Deletion of hepatic Ctr1 reveals its function in copper acquisition and compensatory mechanisms for copper homeostasis. Am J. Physiol. Gastrointest. Liver Physiol. 296(2), G356-G364 (2009).
30. Lee J, Prohaska JR, Thiele DJ. Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc. Natl Acad. Sci. USA 98(12), 6842-6847 (2001).
31. Haremaki T, Fraser ST, Kuo YM, Baron MH, Weinstein DC. Vertebrate Ctr1 coordinates morphogenesis and progenitor cell fate and regulates embryonic stem cell differentiation. Proc. Natl Acad. Sci. USA 104(29), 12029-12034 (2007).
32. Nose Y, Kim BE, Thiele DJ. Ctr1 drives intestinal copper absorption and is essential for growth, iron metabolism, and neonatal cardiac function. Cell Metab. 4(3), 235-244 (2006).
33. Zimnicka AM, Maryon EB, Kaplan JH. Human copper transporter hCTR1 mediates basolateral uptake of copper into enterocytes: implications for copper homeostasis. J. Biol. Chem. 282(36), 26471-26480 (2007).
34. Zerounian NR, Redekosky C, Malpe R, Linder MC. Regulation of copper absorption by copper availability in the Caco-2 cell intestinal model. Am. J. Physiol. Gastrointest. Liver Physiol. 284(5), G739-G747 (2003)
35. Guo Y, Smith K, Lee J, Thiele DJ, Petris MJ. Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J. Biol. Chem. 279(17), 17428-17433 (2004).
36. Guo Y, Smith K, Petris MJ. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters. J. Biol. Chem. 279(45), 46393-46399 (2004).
37. Eisses JF, Kaplan JH. The mechanism of copper uptake mediated by human CTR1: a mutational analysis. J. Biol. Chem. 280(44), 37159-37168 (2005).
38. De Feo CJ, Aller SG, Unger VM. A structural perspective on copper uptake in eukaryotes. Biometals 20(3-4), 705-716 (2007).
39. Maryon EB, Molloy SA, Kaplan JH. O-linked glycosylation at threonine 27 protects the copper transporter hCTR1 from proteolytic cleavage in mammalian cells. J. Biol. Chem. 282(28), 20376-20387 (2007).
40. Jiang J, Nadas IA, Kim MA, Franz KJ. A Mets motif peptide found in copper transport proteins selectively binds Cu(I) with methionine-only coordination. Inorg. Chem. 44(26), 9787-9794 (2005).
41. De Feo CJ, Aller SG, Siluvai GS, Blackburn NJ, Unger VM. Three-dimensional structure of the human copper transporter hCTR1. Proc. Natl Acad. Sci. USA 106(11), 4237-4242 (2009).
42. Puig S, Lee J, Lau M, Thiele DJ. Biochemical and genetic analyses of yeast and human high affinity copper transporters suggest a conserved mechanism for copper uptake. J. Biol. Chem. 277(29), 26021-26030 (2002).
43. Eisses JF, Kaplan JH. Molecular characterization of hCTR1, the human copper uptake protein. J. Biol. Chem. 277(32), 29162-29171 (2002).
44. Sinani D, Adle DJ, Kim H, Lee J. Distinct mechanisms for Ctr1-mediated copper and cisplatin transport. J. Biol. Chem. 282(37), 26775-26785 (2007).
45. Wu X, Sinani D, Kim H, Lee J. Copper transport activity of yeast Ctr1 is downregulated via its C terminus in response to excess copper. J. Biol. Chem. 284(7), 4112-4122 (2009).
46. Xiao Z, Wedd AG. A C-terminal domain of the membrane copper pump Ctr1 exchanges copper(I) with the copper chaperone Atx1. Chem. Commun. (Camb.) 6, 588-589 (2002).
47. Chen HH, Song IS, Hossain A et al. Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1. Mol. Pharmacol. 74(3), 697-704 (2008).
48. Gybina AA, Prohaska JR. Variable response of selected cuproproteins in rat choroid plexus and cerebellum following perinatal copper deficiency. Genes Nutr. 1(1), 51-59 (2006).
49. Klomp AE, Tops BB, Van Denberg IE, Berger R, Klomp LW. Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1). Biochem. J. 364(2), 497-505 (2002).
50. van den Berghe PV, Folmer DE, Malingre HE et al. Human copper transporter 2 is localized in late endosomes and lysosomes and facilitates cellular copper uptake. Biochem. J. 407(1), 49-59 (2007).
51. Bertinato J, Swist E, Plouffe LJ, Brooks SP, L'Abbe MR. Ctr2 is partially localized to the plasma membrane and stimulates copper uptake in COS-7 cells. Biochem. J. 409(3), 731-740 (2008).
52. Rees EM, Thiele DJ. Identification of a vacuole-associated metalloreductase and its role in Ctr2-mediated intracellular copper mobilization. J. Biol. Chem. 282(30), 21629-21638 (2007)
53. Nyasae L, Bustos R, Braiterman L, Eipper B, Hubbard A. Dynamics of endogenous ATP7A (Menkes protein) in intestinal epithelial cells: copper-dependent redistribution between two intracellular sites. Am. J. Physiol. Gastrointest. Liver Physiol. 292(4), G1181-G1194 (2007)
54. Pase L, Voskoboinik I, Greenough M, Camakaris J. Copper stimulates trafficking of a distinct pool of the Menkes copper ATPase (ATP7A) to the plasma membrane and diverts it into a rapid recycling pool. Biochem. J. 378(3), 1031-1037 (2004).
55. Schlief ML, Craig AM, Gitlin JD. NMDA receptor activation mediates copper homeostasis in hippocampal neurons J. Neurosci. 25(1), 239-246 (2005).
56. Hellman NE, Kono S, Mancini GM, Hoogeboom AJ, De Jong GJ, Gitlin JD. Mechanisms of copper incorporation into human ceruloplasmin. J. Biol. Chem. 277(48), 46632-46638 (2002).
57. Qin Z, Itoh S, Jeney V, Ushio-Fukai M, Fukai T. Essential role for the Menkes ATPase in activation of extracellular superoxide dismutase: implication for vascular oxidative stress. Faseb. J. 20(2), 334-336 (2006).
58. di Patti MC, Maio N, Rizzo G et al. Dominant mutants of ceruloplasmin impair the copper loading machinery in aceruloplasminemia. J. Biol. Chem. 284(7), 4545-4554 (2009)
59. Stephenson SE, Dubach D, Lim CM, Mercer JF, La Fontaine S. A single PDZ domain protein interacts with the Menkes copper ATPase, ATP7A. A new protein implicated in copper homeostasis. J. Biol. Chem. 280(39), 33270-33279 (2005).
60. Francis MJ, Jones EE, Levy ER, Martin RL, Ponnambalam S, Monaco AP. Identification of a di-leucine motif within the C terminus domain of the Menkes disease protein that mediates endocytosis from the plasma membrane. J. Cell Sci. 112(11), 1721-1732 (1999).
61. Barnes N, Tsivkovskii R, Tsivkovskaia N, Lutsenko S. The copper-transporting ATPases, menkes and wilson disease proteins, have distinct roles in adult and developing cerebellum. J. Biol. Chem. 280(10), 9640-9645 (2005).
62. Kuhlbrandt W. Biology, structure and mechanism of P-type ATPases. Nat. Rev. Mol. Cell Biol. 5(4), 282-295 (2004).
63. Hatori Y, Hirata A, Toyoshima C, Lewis D, Pilankatta R, Inesi G. Intermediate phosphorylation reactions in the mechanism of ATP utilization by the copper ATPase (CopA) of Thermotoga maritima. J. Biol. Chem. 283(33), 22541-22549 (2008).
64. Leonhardt K, Gebhardt R, Mossner J, Lutsenko S, Huster D. Functional interactions of Cu-ATPase ATP7B with cisplatin and the role of ATP7B in the resistance of cells to the drug. J. Biol. Chem. 284(12), 7793-7802 (2009).
65. Walker JM, Huster D, Ralle M, Morgan CT, Blackburn NJ, Lutsenko S. The N-terminal metal-binding site 2 of the Wilson's disease protein plays a key role in the transfer of copper from Atox1. J. Biol. Chem. 279(15), 15376-15384 (2004).
66. Achila D, Banci L, Bertini I, Bunce J, Ciofi-Baffoni S, Huffman DL. Structure of human Wilson protein domains 5 and 6 and their interplay with domain 4 and the copper chaperone HAH1 in copper uptake. Proc. Natl Acad. Sci. USA 103(15), 5729-5734 (2006).
67. Gonzalez-Guerrero M, Arguello JM. Mechanism of Cu+-transporting ATPases: soluble Cu+ chaperones directly transfer Cu+ to transmembrane transport sites. Proc. Natl Acad. Sci. USA 105(16), 5992-5997 (2008).
68. Huster D, Lutsenko S. The distinct roles of the N-terminal copper-binding sites in regulation of catalytic activity of the Wilson's disease protein. J. Biol. Chem. 278(34), 32212-32218 (2003).
69. Linz R, Lutsenko S. Copper-transporting ATPases ATP7A and ATP7B: cousins, not twins. J. Bioenerg. Biomembr. 39(5-6), 403-407 (2007).
70. Monty JF, Llanos RM, Mercer JF, Kramer DR. Copper exposure induces trafficking of the menkes protein in intestinal epithelium of ATP7A transgenic mice. J. Nutr. 135(12), 2762-2766 (2005).
71. Greenough M, Pase L, Voskoboinik I, Petris MJ, O'Brien AW, Camakaris J. Signals regulating trafficking of Menkes (MNK; ATP7A) copper-translocating P-type ATPase in polarized MDCK cells. Am. J. Physiol. Cell Physiol. 287(5), C1463-C1471 (2004).
72. Roelofsen H, Wolters H, Van Luyn MJ, Miura N, Kuipers F, Vonk RJ. Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion. Gastroenterology 119(3), 782-793 (2000).
73. Hardman B, Michalczyk A, Greenough M, Camakaris J, Mercer JF, Ackland ML. Hormonal regulation of the Menkes and Wilson copper-transporting ATPases in human placental Jeg-3 cells. Biochem. J. 402(2), 241-250 (2007).
74. Barnes N, Bartee MY, Braiterman L et al. Cell-specific trafficking suggests a new role for renal ATP7B in the intracellular copper storage. Traffic 10(6), 767-779 (2009).
75. Weiss KH, Wurz J, Gotthardt D, Merle U, Stremmel W, Fullekrug J. Localization of the Wilson disease protein in murine intestine. J. Anat. 213(3), 232-240 (2008).
76. Finney L, Mandava S, Ursos L et al. X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis. Proc. Natl Acad. Sci. USA 104(7), 2247-2252 (2007).
77. Finney L, Vogt S, Fukai T, Glesne D. Copper and angiogenesis: unravelling a relationship key to cancer progression. Clin. Exp. Pharmacol. Physiol. 36(1), 88-94 (2009).
78. Goodman VL, Brewer GJ, Merajver SD. Copper deficiency as an anti-cancer strategy. Endocr. Relat. Cancer 11(2), 255-263 (2004).
79. Goodman VL, Brewer GJ, Merajver SD. Control of copper status for cancer therapy. Curr. Cancer Drug Targets 5(7), 543-549 (2005).
80. Huster D, Purnat TD, Burkhead JL et al. High copper selectively alters lipid metabolism and cell cycle machinery in the mouse model of Wilson disease. J. Biol. Chem. 282(11), 8343-8355 (2007).
81. Tang Z, Gasperkova D, Xu J, Baillie R, Lee JH, Clarke SD. Copper deficiency induces hepatic fatty acid synthase gene transcription in rats by increasing the nuclear content of mature sterol regulatory element binding protein 1. J. Nutr. 130(12), 2915-2921 (2000).
82. Lang PA, Schenck M, Nicolay JP et al. Liver cell death and anemia in Wilson disease involve acid sphingomyelinase and ceramide. Nat. Med. 13(2), 164-170 (2007).
83. Dunn TM, Haak D, Monaghan E, Beeler TJ. Synthesis of monohydroxylated inositolphosphorylceramide (IPC-C) in Saccharomyces cerevisiae requires Scs7p, a protein with both a cytochrome b5-like domain and a hydroxylase/desaturase domain. Yeast 14(4), 311-321 (1998).
84. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol. 11(1), 107-116 (2001).
85. Itoh S, Kim HW, Nakagawa O et al. Novel role of antioxidant-1 (Atox1) as a copperdependent transcription factor involved in cell proliferation. J. Biol. Chem. 283(14), 9157-9167 (2008).
86. Donley SA, Ilagan BJ, Rim H, Linder MC. Copper transport to mammary gland and milk during lactation in rats. Am. J. Physiol. Endocrinol. Metab. 283(4), E667-E675 (2002).
87. Kelleher SL, Lonnerdal B. Mammary gland copper transport is stimulated by prolactin through alterations in Ctr1 and Atp7A localization. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291(4), R1181-R1191 (2006).
88. Michalczyk A, Bastow E, Greenough M et al. ATP7B expression in human breast epithelial cells is mediated by lactational hormones. J. Histochem. Cytochem. 56(4), 389-399 (2008).
89. Vanderwerf SM, Cooper MJ, Stetsenko IV, Lutsenko S. Copper specifically regulates intracellular phosphorylation of the Wilson's disease protein, a human copper-transporting ATPase. J. Biol. Chem. 276(39), 36289-36294 (2001).
90. Voskoboinik I, Fernando R, Veldhuis N et al. Protein kinase-dependent phosphorylation of the Menkes copper P-type ATPase. Biochem. Biophys. Res. Commun. 303(1), 337-342 (2003).
91. White C, Kambe T, Fulcher YG et al. Copper transport into the secretory pathway is regulated by oxygen in macrophages. J. Cell. Sci. 122(9), 1315-1321 (2009).
92. Reedijk J. Why does Cisplatin reach Guanine-n7 with competing S-donor ligands available in the cell? Chem. Rev. 99(9), 2499-2510 (1999).
93. Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 33(1), 9-23 (2007).
94. Katano K, Kondo A, Safaei R et al. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res. 62(22), 6559-6565 (2002).
95. Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc. Natl Acad. Sci. USA 99(22), 14298-14302 (2002).
96. Rabik CA, Maryon EB, Kasza K, Shafer JT, Bartnik CM, Dolan ME. Role of copper transporters in resistance to platinating agents. Cancer Chemother. Pharmacol. 64(1), 133-142 (2008).
97. Larson CA, Blair BG, Safaei R, Howell SB. The role of the mammalian copper transporter 1 in the cellular accumulation of platinumbased drugs. Mol. Pharmacol. 75(2), 324-330 (2009).
98. Blair BG, Larson CA, Safaei R, Howell SB. Copper transporter 2 regulates the cellular accumulation and cytotoxicity of cisplatin and carboplatin. 15(13), 4312-4321 Clin. Cancer Res. (2009).
99. Samimi G, Safaei R, Katano K et al. Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res. 10(14), 4661-4669 (2004).
100. Mangala LS, Zuzel V, Schmandt R et al. Therapeutic targeting of ATP7B: reversing cisplatin resistance in ovarian carcinoma. Cancer Res. Clin. 15(11), 3770-3780 (2009).
101. Katano K, Safaei R, Samimi G et al. Confocal microscopic analysis of the interaction between cisplatin and the copper transporter ATP7B in human ovarian carcinoma cells. Clin. Cancer Res. 10(13), 4578-4588 (2004).
102. Safaei R, Otani S, Larson BJ, Rasmussen ML, Howell SB. Transport of cisplatin by the copper efflux transporter ATP7B. Mol. Pharmacol. 73(2), 461-468 (2008).
103. Dolgova NV, Olson D, Lutsenko S, Dmitriev OY. The soluble metal-binding domain of the copper transporter ATP7B binds and detoxifies cisplatin. Biochem. J. 419(1), 51-56 (2009).
104. Owatari S, Akune S, Komatsu M et al. Copper-transporting P-type ATPase, ATP7A, confers multidrug resistance and its expression is related to resistance to SN-38 in clinical colon cancer. Cancer Res. 67(10), 4860-4868 (2007).